CID443084

Teva to market cannabis inhaler; FDA makes quality metrics voluntary

This week, Phispers brings you news on J&J’s plans to acquire Actelion and Teva’s ne

Novartis’ plant shut down creates urgency to find alternatives to Chinese APIs

With Novartis shutting two plants in Germany and one in India by 2016-end, the global reliance on Ch

Plan an African safari to discover the world’s fastest growing pharmaceutical opportunity

Africa represents the last geographic frontier where high growth is still achievable. Over the past